About Phage Therapy
Phage therapy is a viable alternative treatment for infection. It is an especially useful tool for chronic and antibiotic resistant infections.
Bacteria like MRSA, ESBL and CRE and VRE are superbugs that have become the scary reality of today’s world.
Phage can target multiple antibiotic resistant infections and also prove advantageous in treating infections which can’t be effectively treated with antibiotics due to poor blood circulation or bacterial biofilms, because of their ability to translocate within wounds and in the body. They are a helpful solution for treatment of infections in people with allergies to antibiotics, they also help protect the bacterial ecology (due to phage specificity) in the gut.
As phage is a naturally occurring organism, it has the ability to adapt and modify to changing antibiotic resistance. Being bacteria’s natural predator, there are great opportunities to discover “new” bacteriophage against those bacteria.
The G. Eliava Institute of Bacteriophage, Microbiology and Virology in Tbilisi, Georgia is one of the world leaders in phage therapy research, and has an unprecedented collection of bacteriophages which can be utilized for developing custom phage preparations.
Phage Treatment Saves a Life
Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center (NMRC), Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages — viruses that target and consume specific strains of bacteria — to treat a patient near death from a multidrug-resistant bacterium.
Phage Therapyat home
skype consultation with your doctor
Phone support during your treatment
Expert Phage Therapy team
Phage Therapyin Georgia
Treatment at the Eliava Institute
Treatments by Phage Therapy specialits
Includes all visits and treatments
Phage Therapyin Spain
State of the art clinic in the Costa del Sol
Experienced team of Doctors
Collaboration with the Eliava Institute